Thyroid Function Test Market - Top Companies and Manufacturers

  • Report ID: 4797
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Companies Dominating the Thyroid Function Test Landscape

    • Abbott
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Quest Diagnostics
    • Eli Lilly and Company
    • Autobio Diagnostics Co., Ltd.
    • BioMérieux SA
    • Danaher Corporation
    • DiaSorin S,p.A.
    • F. Hoffmann-La Roche Ltd.
    • Qualigen Therapeutics Inc.
    • Thermo Fisher Scientific Inc.

Browse Key Market Insights with Data Illustration:

In the News

  • Eli Lilly and Company announced the approval of U.S Food and Drug Administration (FDA) for Retevmo the first medicine particularly approved for the treatment of adult patients with metastatic RET-mutant medullary thyroid cancer. Approval based on results from the largest patient trial yet reported in RET-driven malignancies, LIBRETTO-001 Phase 1/2

  • Quest Diagnostics introduces the very first virtual preventive care service through QuestDirect that is customizable for men and women and gives a health quotient score that can be monitored over time. It uses biometric screening and does a health risk assessment.

 


Author Credits:  Radhika Pawar


  • Report ID: 4797
  • Published Date: Oct 14, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of thyroid function test is assessed at USD 3.41 billion.

The thyroid function test market size was valued at USD 3.18 billion in 2024 and is set to reach USD 9.62 billion by the end of 2037, expanding at around 8.8% CAGR during the forecast period i.e., between 2025-2037. Increasing incidences of thyroid diseases and thyroid cancer, sedentary lifestyle of people, and growing intake of alcohol will boost the market growth.

North America industry is projected to be the largest with a share of about 38% by 2037, owing to rise in the number of people living with thyroid and increasing instances of thyroid cancer in the region.

The major players in the market include Abbott, Quest Diagnostics, Eli Lilly and Company, Autobio Diagnostics Co., Ltd., BioMérieux SA, Danaher Corporation, DiaSorin S, P.A., F. Hoffmann-La Roche Ltd., Qualigen Therapeutics Inc., Thermo Fisher Scientific Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample